Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.310
-0.150 (-3.36%)
At close: Feb 27, 2026, 4:00 PM EST
4.345
+0.035 (0.80%)
After-hours: Feb 27, 2026, 7:59 PM EST
Altimmune Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Altimmune stock have an average target of 16, with a low estimate of 12 and a high estimate of 24. The average target predicts an increase of 271.23% from the current stock price of 4.31.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 7, 2025.
Analyst Ratings
The average analyst rating for Altimmune stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +224.83% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +178.42% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +178.42% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +178.42% | Aug 13, 2025 |
| UBS | UBS | Strong Buy Maintains $26 → $24 | Strong Buy | Maintains | $26 → $24 | +456.84% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
10.74K
from 20.00K
Decreased by -46.32%
Revenue Next Year
4.42K
from 10.74K
Decreased by -58.80%
EPS This Year
-0.99
from -1.34
EPS Next Year
-1.24
from -0.99
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21,000 | 21,000 | ||||
| Avg | 10,736 | 4,424 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.0% | 95.6% | ||||
| Avg | -46.3% | -58.8% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.99 | -1.08 | ||||
| Avg | -0.99 | -1.24 | ||||
| Low | -1.02 | -1.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.